The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...
A young mom was diagnosed with stage four metastatic breast cancer takes part in an experimental treatment with the help of a doctor at Moffitt Cancer Center.